0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antimicrobial Therapeutics Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-15N14238
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Antimicrobial Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Antimicrobial Therapeutics Market Research Report 2024

Code: QYRE-Auto-15N14238
Report
January 2024
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antimicrobial Therapeutics Market Size

The global Antimicrobial Therapeutics market was valued at US$ 199870 million in 2023 and is anticipated to reach US$ 271250 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.

Antimicrobial Therapeutics Market

Antimicrobial Therapeutics Market

An antimicrobial is an agent that kills microorganisms or stops their growth.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antimicrobial Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antimicrobial Therapeutics.

Report Scope

The Antimicrobial Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antimicrobial Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antimicrobial Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Antimicrobial Therapeutics Market Report

Report Metric Details
Report Name Antimicrobial Therapeutics Market
Accounted market size in 2023 US$ 199870 million
Forecasted market size in 2030 US$ 271250 million
CAGR 4.4%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Hospital
  • Clinic
  • Personal
  • Other
Segment by Application
  • Antiviral
  • Antibacterial
  • Antifungal
  • Antiparasitic
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Gilead Sciences, Inc., GlaxoSmithKline plc, Merck & Co Inc., Pfizer Inc., Sanofi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Antimicrobial Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Antimicrobial Therapeutics Market growing?

Ans: The Antimicrobial Therapeutics Market witnessing a CAGR of 4.4% during the forecast period 2024-2030.

What is the Antimicrobial Therapeutics Market size in 2030?

Ans: The Antimicrobial Therapeutics Market size in 2030 will be US$ 271250 million.

Who are the main players in the Antimicrobial Therapeutics Market report?

Ans: The main players in the Antimicrobial Therapeutics Market are Gilead Sciences, Inc., GlaxoSmithKline plc, Merck & Co Inc., Pfizer Inc., Sanofi

What are the Application segmentation covered in the Antimicrobial Therapeutics Market report?

Ans: The Applications covered in the Antimicrobial Therapeutics Market report are Antiviral, Antibacterial, Antifungal, Antiparasitic

What are the Type segmentation covered in the Antimicrobial Therapeutics Market report?

Ans: The Types covered in the Antimicrobial Therapeutics Market report are Hospital, Clinic, Personal, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antimicrobial Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hospital
1.2.3 Clinic
1.2.4 Personal
1.2.5 Other
1.3 Market by Application
1.3.1 Global Antimicrobial Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Antiviral
1.3.3 Antibacterial
1.3.4 Antifungal
1.3.5 Antiparasitic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antimicrobial Therapeutics Market Perspective (2019-2030)
2.2 Antimicrobial Therapeutics Growth Trends by Region
2.2.1 Global Antimicrobial Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antimicrobial Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Antimicrobial Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Antimicrobial Therapeutics Market Dynamics
2.3.1 Antimicrobial Therapeutics Industry Trends
2.3.2 Antimicrobial Therapeutics Market Drivers
2.3.3 Antimicrobial Therapeutics Market Challenges
2.3.4 Antimicrobial Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antimicrobial Therapeutics Players by Revenue
3.1.1 Global Top Antimicrobial Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Antimicrobial Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Antimicrobial Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antimicrobial Therapeutics Revenue
3.4 Global Antimicrobial Therapeutics Market Concentration Ratio
3.4.1 Global Antimicrobial Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antimicrobial Therapeutics Revenue in 2023
3.5 Antimicrobial Therapeutics Key Players Head office and Area Served
3.6 Key Players Antimicrobial Therapeutics Product Solution and Service
3.7 Date of Enter into Antimicrobial Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antimicrobial Therapeutics Breakdown Data by Type
4.1 Global Antimicrobial Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Antimicrobial Therapeutics Forecasted Market Size by Type (2025-2030)
5 Antimicrobial Therapeutics Breakdown Data by Application
5.1 Global Antimicrobial Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Antimicrobial Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antimicrobial Therapeutics Market Size (2019-2030)
6.2 North America Antimicrobial Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antimicrobial Therapeutics Market Size by Country (2019-2024)
6.4 North America Antimicrobial Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antimicrobial Therapeutics Market Size (2019-2030)
7.2 Europe Antimicrobial Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antimicrobial Therapeutics Market Size by Country (2019-2024)
7.4 Europe Antimicrobial Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antimicrobial Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Antimicrobial Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antimicrobial Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Antimicrobial Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antimicrobial Therapeutics Market Size (2019-2030)
9.2 Latin America Antimicrobial Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antimicrobial Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Antimicrobial Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antimicrobial Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Antimicrobial Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antimicrobial Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Antimicrobial Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences, Inc.
11.1.1 Gilead Sciences, Inc. Company Detail
11.1.2 Gilead Sciences, Inc. Business Overview
11.1.3 Gilead Sciences, Inc. Antimicrobial Therapeutics Introduction
11.1.4 Gilead Sciences, Inc. Revenue in Antimicrobial Therapeutics Business (2019-2024)
11.1.5 Gilead Sciences, Inc. Recent Development
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Company Detail
11.2.2 GlaxoSmithKline plc Business Overview
11.2.3 GlaxoSmithKline plc Antimicrobial Therapeutics Introduction
11.2.4 GlaxoSmithKline plc Revenue in Antimicrobial Therapeutics Business (2019-2024)
11.2.5 GlaxoSmithKline plc Recent Development
11.3 Merck & Co Inc.
11.3.1 Merck & Co Inc. Company Detail
11.3.2 Merck & Co Inc. Business Overview
11.3.3 Merck & Co Inc. Antimicrobial Therapeutics Introduction
11.3.4 Merck & Co Inc. Revenue in Antimicrobial Therapeutics Business (2019-2024)
11.3.5 Merck & Co Inc. Recent Development
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Detail
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Antimicrobial Therapeutics Introduction
11.4.4 Pfizer Inc. Revenue in Antimicrobial Therapeutics Business (2019-2024)
11.4.5 Pfizer Inc. Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Antimicrobial Therapeutics Introduction
11.5.4 Sanofi Revenue in Antimicrobial Therapeutics Business (2019-2024)
11.5.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Antimicrobial Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Hospital
    Table 3. Key Players of Clinic
    Table 4. Key Players of Personal
    Table 5. Key Players of Other
    Table 6. Global Antimicrobial Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Antimicrobial Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Antimicrobial Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Antimicrobial Therapeutics Market Share by Region (2019-2024)
    Table 10. Global Antimicrobial Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Antimicrobial Therapeutics Market Share by Region (2025-2030)
    Table 12. Antimicrobial Therapeutics Market Trends
    Table 13. Antimicrobial Therapeutics Market Drivers
    Table 14. Antimicrobial Therapeutics Market Challenges
    Table 15. Antimicrobial Therapeutics Market Restraints
    Table 16. Global Antimicrobial Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Antimicrobial Therapeutics Market Share by Players (2019-2024)
    Table 18. Global Top Antimicrobial Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Therapeutics as of 2023)
    Table 19. Ranking of Global Top Antimicrobial Therapeutics Companies by Revenue (US$ Million) in 2023
    Table 20. Global 5 Largest Players Market Share by Antimicrobial Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Antimicrobial Therapeutics Product Solution and Service
    Table 23. Date of Enter into Antimicrobial Therapeutics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Antimicrobial Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Antimicrobial Therapeutics Revenue Market Share by Type (2019-2024)
    Table 27. Global Antimicrobial Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Antimicrobial Therapeutics Revenue Market Share by Type (2025-2030)
    Table 29. Global Antimicrobial Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Antimicrobial Therapeutics Revenue Market Share by Application (2019-2024)
    Table 31. Global Antimicrobial Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Antimicrobial Therapeutics Revenue Market Share by Application (2025-2030)
    Table 33. North America Antimicrobial Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 34. North America Antimicrobial Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 35. North America Antimicrobial Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 36. Europe Antimicrobial Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. Europe Antimicrobial Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 38. Europe Antimicrobial Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Asia-Pacific Antimicrobial Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Asia-Pacific Antimicrobial Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 41. Asia-Pacific Antimicrobial Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 42. Latin America Antimicrobial Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Latin America Antimicrobial Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Antimicrobial Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Antimicrobial Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Middle East & Africa Antimicrobial Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Middle East & Africa Antimicrobial Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 48. Gilead Sciences, Inc. Company Detail
    Table 49. Gilead Sciences, Inc. Business Overview
    Table 50. Gilead Sciences, Inc. Antimicrobial Therapeutics Product
    Table 51. Gilead Sciences, Inc. Revenue in Antimicrobial Therapeutics Business (2019-2024) & (US$ Million)
    Table 52. Gilead Sciences, Inc. Recent Development
    Table 53. GlaxoSmithKline plc Company Detail
    Table 54. GlaxoSmithKline plc Business Overview
    Table 55. GlaxoSmithKline plc Antimicrobial Therapeutics Product
    Table 56. GlaxoSmithKline plc Revenue in Antimicrobial Therapeutics Business (2019-2024) & (US$ Million)
    Table 57. GlaxoSmithKline plc Recent Development
    Table 58. Merck & Co Inc. Company Detail
    Table 59. Merck & Co Inc. Business Overview
    Table 60. Merck & Co Inc. Antimicrobial Therapeutics Product
    Table 61. Merck & Co Inc. Revenue in Antimicrobial Therapeutics Business (2019-2024) & (US$ Million)
    Table 62. Merck & Co Inc. Recent Development
    Table 63. Pfizer Inc. Company Detail
    Table 64. Pfizer Inc. Business Overview
    Table 65. Pfizer Inc. Antimicrobial Therapeutics Product
    Table 66. Pfizer Inc. Revenue in Antimicrobial Therapeutics Business (2019-2024) & (US$ Million)
    Table 67. Pfizer Inc. Recent Development
    Table 68. Sanofi Company Detail
    Table 69. Sanofi Business Overview
    Table 70. Sanofi Antimicrobial Therapeutics Product
    Table 71. Sanofi Revenue in Antimicrobial Therapeutics Business (2019-2024) & (US$ Million)
    Table 72. Sanofi Recent Development
    Table 73. Research Programs/Design for This Report
    Table 74. Key Data Information from Secondary Sources
    Table 75. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Antimicrobial Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Antimicrobial Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Hospital Features
    Figure 4. Clinic Features
    Figure 5. Personal Features
    Figure 6. Other Features
    Figure 7. Global Antimicrobial Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Antimicrobial Therapeutics Market Share by Application: 2023 VS 2030
    Figure 9. Antiviral Case Studies
    Figure 10. Antibacterial Case Studies
    Figure 11. Antifungal Case Studies
    Figure 12. Antiparasitic Case Studies
    Figure 13. Antimicrobial Therapeutics Report Years Considered
    Figure 14. Global Antimicrobial Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Antimicrobial Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Antimicrobial Therapeutics Market Share by Region: 2023 VS 2030
    Figure 17. Global Antimicrobial Therapeutics Market Share by Players in 2023
    Figure 18. Global Top Antimicrobial Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Therapeutics as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Antimicrobial Therapeutics Revenue in 2023
    Figure 20. North America Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Antimicrobial Therapeutics Market Share by Country (2019-2030)
    Figure 22. United States Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Antimicrobial Therapeutics Market Share by Country (2019-2030)
    Figure 26. Germany Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Antimicrobial Therapeutics Market Share by Region (2019-2030)
    Figure 34. China Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Japan Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. South Korea Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Southeast Asia Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. India Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Australia Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Antimicrobial Therapeutics Market Share by Country (2019-2030)
    Figure 42. Mexico Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Brazil Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Antimicrobial Therapeutics Market Share by Country (2019-2030)
    Figure 46. Turkey Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Saudi Arabia Antimicrobial Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Gilead Sciences, Inc. Revenue Growth Rate in Antimicrobial Therapeutics Business (2019-2024)
    Figure 49. GlaxoSmithKline plc Revenue Growth Rate in Antimicrobial Therapeutics Business (2019-2024)
    Figure 50. Merck & Co Inc. Revenue Growth Rate in Antimicrobial Therapeutics Business (2019-2024)
    Figure 51. Pfizer Inc. Revenue Growth Rate in Antimicrobial Therapeutics Business (2019-2024)
    Figure 52. Sanofi Revenue Growth Rate in Antimicrobial Therapeutics Business (2019-2024)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS